Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Business & Industry
- Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure
- Nearly 700,000 US hospitalizations and 110,000 deaths prevented from the Pfizer-BioNTech COVID-19 vaccine
- Pfizer and BioNTech provide update on COVID-19 vaccine supply agreement with European Commission
- Roche pledges to extend commitment to the World Federation of Hemophilia Humanitarian Aid Program to 2028
- Pfizer to acquire Biohaven Pharmaceuticals
Research & Development
- "Natural immunity" from omicron is weak and limited, study finds
- mRNA booster vaccines may be a good investment in developing countries
- Blocking spike captors to counter COVID
- Recurring brain tumor growth is halted with new drug
- Investigational COVID mucosal vaccine protects against disease and transmission
- Using AI to analyze large amounts of biological data
- Cognitive impairment from severe COVID-19 equivalent to 20 years of ageing, study finds
Conferences & Events
- Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
- SMi's 22nd Annual Pain Therapeutics Conference
- SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
- SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
- SMi's 3rd Annual AI in Drug Discovery Conference
- SMi's 6th Annual Highly Potent Active Pharmaceutical Ingredients
- SMi's 9th Annual Conference Pre-Filled Syringes East Coast
Regulatory Affairs
- FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
- FDA limits use of Janssen COVID-19 vaccine to certain individuals
- EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
- FDA approves first generic of Symbicort to treat asthma and COPD
- FDA approves treatment for wider range of patients with heart failure